Facial Plast Surg 2014; 30(06): 615-622
DOI: 10.1055/s-0034-1396904
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Complications of Collagen Fillers

Patricia Lucey
1   Department of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, New York, New York
,
David J. Goldberg
2   Skin Laser and Surgery Specialists of NY/NJ, New Jersey
3   Department of Dermatology, Mount Sinai School of Medicine, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2014 (online)

Abstract

As the skin ages, a deficiency in collagen occurs, thus injectable collagen products have become a sensible and popular option for dermal filling and volume enhancement. Several types of collagen have been developed over the years, including animal sources such as bovine and porcine collagen, as well as human-based sources derived from pieces of the patient's own skin, cadaver skin, and later cultured from human dermal fibroblasts. While collagen overall has a relatively safe, side effect profile, there are several complications, both early and late onset, that practitioners and patients should be aware of. Early complications, occurring within days of the procedure, can be divided into non-hypersensitivity and hypersensitivity reactions. The non-hypersensitive reactions include injection site reactions, discoloration, maldistribution, infection, skin necrosis, and the very rare but dreaded risk of vision loss, whereas the hypersensitivity reactions present usually as delayed type IV reactions, but can also rarely present as an immediate type I reaction. Late complications, occurring within weeks to even years after injection, include granuloma formation, foreign body reactions, and infection secondary to atypical mycobacteria or biofilms. This review will give a detailed overview of the complications secondary to cutaneous collagen injections.

Note

The authors have not received any financial support or personal assistance for this study.


 
  • References

  • 1 Baumann L, Kaufman J, Saghari S. Collagen fillers. Dermatol Ther 2006; 19 (3) 134-140
  • 2 Lavker RM. Structural alterations in exposed and unexposed aged skin. J Invest Dermatol 1979; 73 (1) 59-66
  • 3 Fisher GJ, Datta SC, Talwar HS , et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379 (6563) 335-339
  • 4 Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337 (20) 1419-1428
  • 5 Cockerham K, Hsu VJ. Collagen-based dermal fillers: past, present, future. Facial Plast Surg 2009; 25 (2) 106-113
  • 6 Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64 (1) 1-34 , quiz 35–36
  • 7 Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Dermal fillers: types, indications, and complications [in Spanish]. Actas Dermosifiliogr 2010; 101 (5) 381-393
  • 8 Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthet Surg J 2011; 31 (1) 110-121
  • 9 Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 (Suppl. 01) S92-S99
  • 10 Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29 (6) 573-587 , discussion 587
  • 11 Hirsch RJ, Stier M. Complications of soft tissue augmentation. J Drugs Dermatol 2008; 7 (9) 841-845
  • 12 Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991; 25 (2 Pt 1) 319-326
  • 13 Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers—focal necrosis and angry red bumps. Dermatol Surg 2006; 32 (3) 426-434
  • 14 Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006; 32 (2) 276-281
  • 15 Castrow II FF, Krull EA. Injectable collagen implant—update. J Am Acad Dermatol 1983; 9 (6) 889-893
  • 16 DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987; 79 (4) 581-594
  • 17 McGrew RN, Wilson RS, Havener WH. Sudden blindness secondary to injections of common drugs in the head and neck: I. Clinical experiences. Otolaryngology 1978; 86 (1) ORL-147-ORL-151
  • 18 Silva MT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 2004; 62 (3B, 3b): 873-874
  • 19 Braun M, Braun S. Nodule formation following lip augmentation using porcine collagen-derived filler. J Drugs Dermatol 2008; 7 (6) 579-581
  • 20 Klein AW. Skin filling. Collagen and other injectables of the skin. Dermatol Clin 2001; 19 (3) 491-508 , ix
  • 21 Siegle RJ, McCoy Jr JP, Schade W, Swanson NA. Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 1984; 120 (2) 183-187
  • 22 Glavas IP. Filling agents. Ophthalmol Clin North Am 2005; 18 (2) 249-257 , v–vi
  • 23 Pollack S. Some new injectable dermal filler materials: Hylaform, Restylane, and Artecoll. J Cutan Med Surg 1999; 3 (Suppl. 04) S27-S35
  • 24 Moody BR, Sengelmann RD. Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 2001; 27 (9) 789-791
  • 25 Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 1999; 25 (3) 247-249
  • 26 Douglas RS, Donsoff I, Cook T, Shorr N. Collagen fillers in facial aesthetic surgery. Facial Plast Surg 2004; 20 (2) 117-123
  • 27 Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Ophthalmol 1996; 24 (3) 257-260
  • 28 Stolman LP. Human collagen reactions. Dermatol Surg 2005; 31 (11, Pt 2) 1634
  • 29 Barr RJ, King DF, McDonald RM, Bartlow GA. Necrobiotic granulomas associated with bovine collagen test site injections. J Am Acad Dermatol 1982; 6 (5) 867-869
  • 30 Rapaport MJ. Granuloma annulare caused by injectable collagen. Arch Dermatol 1984; 120 (7) 837-838
  • 31 García-Domingo MI, Alijotas-Reig J, Cisteró-Bahima A, Tresserra F, Enrique E. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Investig Allergol Clin Immunol 2000; 10 (2) 107-109
  • 32 Brongo S, Moccia LS, Nunziata V, D'Andrea F. Keratoacanthoma arising after site injection infection of cosmetic collagen filler. Int J Surg Case Rep 2013; 4 (4) 429-431
  • 33 Fischer J, Metzler G, Schaller M. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 2007; 143 (4) 507-510
  • 34 Piacquadio D, Smith S, Anderson R. A comparison of commercially available polymethylmethacrylate-based soft tissue fillers. Dermatol Surg 2008; 34 (Suppl. 01) S48-S52
  • 35 Lemperle G, Hazan-Gaúthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft-tissue augmentation. Part II: Clinical investigations. Plast Reconstr Surg 1995; 96 (3) 627-634
  • 36 Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg 2003; 29 (8) 859-862
  • 37 Requena C, Izquierdo MJ, Navarro M , et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 2001; 23 (3) 197-202
  • 38 Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 2003; 139 (1) 17-20
  • 39 Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 2006; 32 (8) 1079-1081 , discussion 1082
  • 40 Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003; 29 (9) 971-973
  • 41 Bentkover SH. The biology of facial fillers. Facial Plast Surg 2009; 25 (2) 73-85
  • 42 Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 2010; 125 (4) 1250-1256
  • 43 Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29 (1) 34-48
  • 44 van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001; 72 (6) 557-571
  • 45 Hoffmann N, Lee B, Hentzer M , et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007; 51 (10) 3677-3687
  • 46 Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118 (3, Suppl): 92S-107S
  • 47 Cukier J, Beauchamp RA, Spindler JS, Spindler S, Lorenzo C, Trentham DE. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 1993; 118 (12) 920-928
  • 48 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. I. A 1-year prospective study. J Am Acad Dermatol 1984; 10 (4) 638-646
  • 49 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 1984; 10 (4) 647-651
  • 50 Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J. The human immune response to reconstituted bovine collagen. J Immunol 1986; 136 (3) 877-882
  • 51 Hanke CW, Thomas JA, Lee WT, Jolivette DM, Rosenberg MJ. Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants. J Am Acad Dermatol 1996; 34 (3) 450-454
  • 52 Rosenberg MJ, Reichlin M. Is there an association between injectable collagen and polymyositis/dermatomyositis?. Arthritis Rheum 1994; 37 (5) 747-753